Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0000947871-23-000743
Filing Date
2023-07-12
Accepted
2023-07-12 09:49:06
Documents
1
Effectiveness Date
2023-07-12
Items
Item 06b:
Item 3C: Investment Company Act Section 3(c)
Item 3C.7: Section 3(c)(7)

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 13053
  Complete submission text file 0000947871-23-000743.txt   14294
Mailing Address 601 LEXINGTON AVENUE, 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE, 54TH FLOOR NEW YORK NY 10022 212-739-6400
OrbiMed Partners II, L.P. (Filer) CIK: 0001324240 (see all company filings)

EIN.: 134012775 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-128771 | Film No.: 231083414